Login / Signup

Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.

Rodney Daniel Sinclair
Published in: International journal of dermatology (2017)
Once daily capsules containing minoxidil 0.25 mg and spironolactone 25 mg appear to be safe and effective in the treatment of FPHL. Placebo-controlled studies to investigate this further are warranted.
Keyphrases
  • combination therapy
  • low dose
  • placebo controlled
  • double blind
  • high dose
  • randomized controlled trial
  • study protocol
  • squamous cell carcinoma